Médecins Sans Frontières Wraps Up Tuberculosis Project in Dushanbe, Tajikistan: A Timeline of Achievements
June 19, 2024Dushanbe, Tajikistan – As Médecins Sans Frontières (MSF) concludes its tuberculosis (TB) project in Dushanbe, Tajikistan, after 13 years of collaboration with the Ministry of Health and Social Protection of Population, we reflect on the programme's journey.MSF’s work in Dushanbe...
Read moreIndia: Mumbai TB Symposium Focuses on Advancing TB Treatment and Collaboration
June 11, 202410 June 2024, Mumbai: A pivotal symposium organised today by Médecins Sans Frontières (MSF)/Doctors Without Borders brought together a diverse coalition of experts and stakeholders to forge actionable strategies against Drug-Resistant Tuberculosis (DRTB). This crucial gathering aimed to highlight the...
Read moreUrgent call for Europe to improve treatment access for tuberculosis: Many TB medicines and formulations accessible in lower- and middle-income countries remain unaffordable or unavailable in Europe
June 7, 2024Berlin, 6 June 2024: As the World Health Organization (WHO) concluded a meeting with European health officials and civil society to improve access to tuberculosis (TB) medicines in the European Union (EU)/European Economic Area (EEA), Médecins Sans Frontières/Doctors Without Borders...
Read moreSouth Sudan: How malnutrition is dangerously feeding the TB/HIV pandemic
May 30, 2024In South Sudan, over seven million people are expected to face acute food insecurity or worse between now and July. Among them, patients who are infected with tuberculosis and HIV are highly impacted since the intensity of the treatment is...
Read moreTime for $5: MSF demands Cepheid and Danaher lower the price of medical tests
March 22, 2024Help us stop the profiteering on medical tests Sign the petition to demand drug manufacturers Cepheid and Danaher drop the price of GeneXpert tests for low- and middle-income countries. MSF and partners protest outside Danaher in Washington, DC, demanding price...
Read morePatient Stories: Ensuring recovery through timely, accurate drug-resistant tuberculosis testing
March 18, 2024Ahmad, 11, from Tatlay Aali, a town in Gujranwala district, Pakistan, was diagnosed with tuberculosis (TB) when he was just five years old. "We’d never heard about this disease, nobody from our family ever had it. At the same time,...
Read moreTuberculosis: Increased diagnostic testing for drug resistance will enhance patients’ treatment outcome
March 18, 2024Islamabad: On World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières (MSF) encourages medical service providers and practitioners in Pakistan to enhance drug resistant tuberculosis (DRTB) diagnosis by increasing the use of GeneXpert diagnostic testing among suspect tuberculosis (TB) cases. Additionally,...
Read moreMSF launches unprecedented project to tackle under-diagnosed tuberculosis among children
March 18, 2024Tuberculosis (TB) in children is a silent scourge: one child dies of TB every three minutes and more than half of all children with TB are never diagnosed. Taking the opportunity of a set of new recommendations by the World...
Read moreLandmark clinical trial redefines multidrug-resistant tuberculosis Treatment options
November 15, 2023endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis Paris, France; November 15, 2023 – Clinical trial results presented for the first time today at the Union World Conference on Lung Health...
Read moreMSF warns governments are failing to test, treat and prevent TB in children
November 14, 2023Governments must immediately implement the latest WHO guidelines to stop children from dying from this deadly yet curable disease Geneva, 14 November 2023 - Médecins Sans Frontières/Doctors Without Borders (MSF) welcomed the World Health Organization’s (WHO) ‘Roadmap towards ending TB in...
Read moreMSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease
November 7, 2023The World Health Organization’s (WHO) 2023 Global Tuberculosis (TB) Report released today shows that the estimated global incidence of TB in 2022 remains unacceptably high, including for the more difficult to treat form of this disease, drug-resistant TB (DR-TB). With...
Read moreMSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
July 18, 2023MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics. Recent deal offering controlled generics access in limited countries does not go...
Read more